V
52.52
2.23 (4.43%)
| Penutupan Terdahulu | 50.29 |
| Jumlah Dagangan | 1,834,513 |
| Harga / Pendapatan (P/E Ke hadapan) | 27.05 |
| Harga / Jualan (P/S) | 7.30 |
| Harga / Buku (P/B) | 2.91 |
| Julat 52 Minggu |
| Margin Keuntungan | 7.13% |
| Margin Operasi (TTM) | 7.03% |
| EPS Cair (TTM) | 0.420 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 18.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.23% |
| Nisbah Semasa (MRQ) | 5.10 |
| Aliran Tunai Operasi (OCF TTM) | 89.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 76.93 M |
| Pulangan Atas Aset (ROA TTM) | 1.94% |
| Pulangan Atas Ekuiti (ROE TTM) | 2.86% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Veracyte, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | -0.6 |
| Volatiliti Harga | -2.8 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 2.4 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.46 |
|
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.54% |
| % Dimiliki oleh Institusi | 107.98% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| EASTHAM KARIN | - | 50.28 | -14,850 | -746,658 |
| HOLSTEIN JENS | - | 50.28 | -7,500 | -377,100 |
| WYGANT JONATHAN | - | 50.31 | -1,306 | -65,705 |
| Jumlah Keseluruhan Kuantiti Bersih | -23,656 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,189,463 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 50.28 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| WYGANT JONATHAN | Pegawai | 28 Oct 2026 | Dibuang (-) | 1,306 | 50.31 | 65,705 |
| EASTHAM KARIN | Pengarah | 27 Oct 2026 | Jual automatik (-) | 14,850 | 50.28 | 746,658 |
| EASTHAM KARIN | Pengarah | 27 Oct 2026 | Pelaksanaan pilihan | 10,000 | - | - |
| HOLSTEIN JENS | Pengarah | 27 Oct 2026 | Jual automatik (-) | 7,500 | 50.28 | 377,100 |
| HOLSTEIN JENS | Pengarah | 27 Oct 2026 | Pelaksanaan pilihan | 7,500 | - | - |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |